New paradigms and future challenges in radiation oncology: an update of biological targets and technology

SL Liauw, PP Connell, RR Weichselbaum - Science translational …, 2013 - science.org
Radiation oncology exploits the biological interaction of radiation within tissue to promote
tumor death while minimizing damage to surrounding normal tissue. The clinical delivery of …

Progress and problems with the use of suicide genes for targeted cancer therapy

Z Karjoo, X Chen, A Hatefi - Advanced drug delivery reviews, 2016 - Elsevier
Among various gene therapy methods for cancer, suicide gene therapy attracts a special
attention because it allows selective conversion of non-toxic compounds into cytotoxic drugs …

RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells

JM Mason, K Dusad, WD Wright, J Grubb… - Nucleic acids …, 2015 - academic.oup.com
The RAD54 family DNA translocases have several biochemical activities. One activity,
demonstrated previously for the budding yeast translocases, is ATPase-dependent …

Targeted diphtheria toxin-based therapy: a review article

F Shafiee, MG Aucoin… - Frontiers in …, 2019 - frontiersin.org
Cancer remains one of the leading causes of death worldwide. Conventional therapeutic
strategies usually offer limited specificity, resulting in severe side effects and toxicity to …

Regulation and pharmacological targeting of RAD51 in cancer

MKK Grundy, RJ Buckanovich, KA Bernstein - NAR cancer, 2020 - academic.oup.com
Regulation of homologous recombination (HR) is central for cancer prevention. However,
too little HR can increase cancer incidence, whereas too much HR can drive cancer …

RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells

B Budke, HL Logan, JH Kalin… - Nucleic acids …, 2012 - academic.oup.com
Homologous recombination serves multiple roles in DNA repair that are essential for
maintaining genomic stability. We here describe RI-1, a small molecule that inhibits the …

SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells

M Van Meter, Z Mao, V Gorbunova, A Seluanov - Cell cycle, 2011 - Taylor & Francis
Emerging evidence suggests that Sirtuin 6 (SIRT6) functions as a longevity assurance gene
by promoting genomic stability, regulating metabolic processes and attenuating …

RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies

M Gachechiladze, J Škarda… - … Journal of Cancer, 2017 - Wiley Online Library
Targeting deficient mechanisms of cellular DNA repair still represents the basis for the
treatment of the majority of solid tumors, and increased DNA repair capacity is a hallmark …

Toxin-based therapeutic approaches

A Shapira, I Benhar - Toxins, 2010 - mdpi.com
Protein toxins confer a defense against predation/grazing or a superior pathogenic
competence upon the producing organism. Such toxins have been perfected through …

Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51

A Ward, KK Khanna, AP Wiegmans - Cancer treatment reviews, 2015 - Elsevier
The DNA damage response (DDR) is essential for maintaining genomic stability and cell
survival. However, when tumour cells with deficiencies in HR are faced with radio-and …